Theriva Biologics Inc (TOVX)
0.4195
+0.01
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
0.4199
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Cash from Financing (TTM): 0.625M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.625M |
September 30, 2023 | -1.206M |
June 30, 2023 | 1.527M |
March 31, 2023 | -0.609M |
December 31, 2022 | -1.93M |
September 30, 2022 | 1.358M |
June 30, 2022 | -1.376M |
March 31, 2022 | -1.376M |
December 31, 2021 | 74.00M |
September 30, 2021 | 77.36M |
June 30, 2021 | 77.36M |
March 31, 2021 | 77.36M |
December 31, 2020 | 3.359M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 22.67M |
June 30, 2019 | 28.69M |
March 31, 2019 | 29.09M |
December 31, 2018 | 29.09M |
September 30, 2018 | 6.423M |
June 30, 2018 | 12.80M |
March 31, 2018 | 18.04M |
December 31, 2017 | 18.48M |
Date | Value |
---|---|
September 30, 2017 | 43.74M |
June 30, 2017 | 31.98M |
March 31, 2017 | 27.14M |
December 31, 2016 | 26.71M |
September 30, 2016 | 1.473M |
June 30, 2016 | 43.49M |
March 31, 2016 | 42.68M |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | 19.03M |
September 30, 2014 | 12.20M |
June 30, 2014 | 12.20M |
March 31, 2014 | 12.20M |
December 31, 2013 | 12.43M |
September 30, 2013 | 10.38M |
June 30, 2013 | 10.48M |
March 31, 2013 | 10.89M |
December 31, 2012 | 12.20M |
September 30, 2012 | 2.059M |
June 30, 2012 | 1.965M |
March 31, 2012 | 4.806M |
December 31, 2011 | 6.979M |
September 30, 2011 | 6.987M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.93M
Minimum
Dec 2022
77.36M
Maximum
Mar 2021
18.83M
Average
0.625M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Oragenics Inc | 0.2839M |
Nanoviricides Inc | 0.00 |